Synapsoft logo
AI Insights from Disclosures
Searching...
Mezzion Pharma Co., Ltd. 140410
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Mezzion Pharma Co., Ltd. was established on September 25, 2002, with pharmaceutical manufacturing and sales as its main business purpose, and it has focused on global new drug development since its founding. The company has conducted global development for the treatment of various diseases, including erectile dysfunction, benign prostatic hyperplasia, portal hypertension, pulmonary arterial hypertension, and single ventricle disease, and it has carried out licensing-out and exports related to these treatments in major countries including the United States.
Representative Director Park Donghyeon
Founded September 25, 2002
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 11011-2615578
Business number 204-81-72221
Phone Number 02-560-8000
Fax Number 02-566-6517
Website None
Company Address 570 Samseong-ro, Gangnam-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant